Spain· ES:08502001
MEPACT 4 mg POLVO PARA SUSPENSION PARA PERFUSION
A medicinal product containing mifamurtida, registered in Spain by Esteve Pharmaceuticals S.A..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- mifamurtida
- Manufacturer
- Esteve Pharmaceuticals S.A.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mifamurtida in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomMepact 4mg powder for concentrate for dispersion for infusion vialsTakeda UK Ltd
- CzechiaMEPACTEsteve Pharmaceuticals S.A., Barcelona
- FinlandMEPACTEsteve Pharmaceuticals, S.A
- IrelandMepact 4 mg Powder for concentrate for dispersion for infusionEsteve Pharmaceuticals S.A.
- IcelandMepactEsteve Pharmaceuticals S.A.
- NetherlandsMepact, poeder voor suspensie voor intraveneuze infusie, 4 mgEsteve Pharmaceuticals S.A.
- PolandMepactEsteve Pharmaceuticals, S.A.
- BelgiumMepact 4 mgEsteve Pharmaceuticals
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Mepact
- Liechtenstein · Mepact
- Norway · Mepact
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ffcca54d-de67-4264-a264-59da150decb1 GET /v1/drugs/ffcca54d-de67-4264-a264-59da150decb1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1270764000000}",
"nregistro": "08502001",
"substance": "mifamurtida"
}See everything about mifamurtida.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.